Publish Artefact and Determine Progression
Upload the final Evidence-to-Decision Traceability asset into the venture's data room and record updated venture DNA entries. The founder reviews the output against programme milestones to determine whether to advance, repeat validation, escalate for expert review, or transition stages.
Updating the data room formalises the venture's current evidence state and maintains transparency for advisors and investors. Choosing the next task based on matrix findings ensures resource allocation remains tightly coupled to empirical proof.
A published data-room asset titled 'Evidence-to-Decision Traceability', an updated venture DNA record reflecting validated claims, and a documented decision on the immediate next task.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How does the published traceability matrix change your narrative to external investors in the data room?
- 2
What specific trigger in this asset dictates whether you progress to solution building or repeat discovery?
- 3
How have you reflected newly exposed risks or invalidated claims in your updated venture DNA?
- 4
Why is the recommended next task the most efficient use of resources given the gaps identified?
- 5
How will you maintain this traceability asset as an ongoing operational tool rather than a static document?